Acipta vs Drata — continuous monitoring vs continuous evidence.

Acipta vs Drata — Continuous Monitoring vs Continuous Compliance

Drata built a cleaner monitoring UX than most. Acipta built a different theory of what monitoring is for. The distinction matters more at the second framework than the first.

TL;DR

Drata is a continuous-monitoring compliance platform — sharper UX than Vanta in many G2 reviews, similar SOC 2 + ISO 27001 + HIPAA + GDPR + CCPA breadth, documentation-led evidence model. Acipta is an agent-based defensibility platform — workflow-grounded — that ships 7 GA suites · 117 agents from a single cryptographically signed evidence chain, replayable for five years.

Choose Drata if SOC 2 is the program, continuous monitoring is the priority, and you prefer the Drata UX to Vanta's. Choose Acipta if your Chief Compliance Officer needs continuous evidence — signed at write time, framework-mapped at read time — across a growing portfolio.

Targets and timelines below are aspirational; pre-customer baseline applies. Acipta achieved-vs-target published weekly post-GA (2026-08-23).

At-a-glance

Why this comparison matters

Drata and Acipta share more than Drata and Vanta do — both lean into "continuous" as the architectural commitment. The difference is what each platform makes continuous.

Drata's "continuous" = continuous monitoring. When your AWS configuration drifts, Drata sees the drift and surfaces it on the dashboard. When an Okta user gets added to an admin group without approval, Drata flags it. The continuous part is the watching.

Acipta's "continuous" = continuous evidence. Every agent execution emits a signed verdict. Every signed verdict joins the evidence chain at write time. When the auditor asks "prove this control was in place on March 14," the same agent run that lit up the dashboard on March 14 is replayable byte-identically five years later. The continuous part is the cryptographic chain.

Both architectures handle the SOC 2 use case competently. The architectural delta widens as the framework portfolio grows.

The architectural difference

Drata's architecture is well-engineered for the bet it's making. The bet is that documentation-grade evidence with continuous monitoring is sufficient for most compliance audits. For SOC 2 Type 2, that bet pays off — SOC 2 auditors accept documentation-as-evidence and value monitoring posture.

Acipta's bet is different: that documentation-as-evidence has a ceiling, and the ceiling is hit at the second framework (HIPAA, GDPR, EU AI Act), at the first regulator inquiry, or at the first major-customer procurement review that asks for tamper-evident records. Different bet, different architecture.

Detailed comparison

Continuous monitoring vs continuous evidence

Drata: continuous monitoring of integration state. Sharp UX for surfacing drift. Strong G2 reviews on monitoring cadence and alert quality. Auditor receives exported documentation at audit time. Strength: monitoring posture is sharper than Vanta's quarterly cadence. Limitation: monitoring is about state changes; evidence is about what happened and when. They're related but not the same artifact.

Acipta: continuous evidence emission. Each of 117 agents emits signed verdicts on its execution cadence. Verdicts join the chain at write time with cryptographic signatures and timestamps. The auditor receives the verdicts themselves, not exports. Strength: evidence is tamper-evident and replayable. The same artifact that produced the dashboard moment IS the audit artifact. Limitation: cryptographic infrastructure costs are real; Acipta has architected for these to net out at ~0.5 cents per verdict aggregated. Drata's documentation-led architecture is cheaper to operate per record.

Bottom line: monitoring tells you what changed. Evidence proves what happened. For SOC 2, monitoring is often sufficient. For HIPAA Privacy Rule § 164.520, GDPR Article 30 records-of-processing, ADA Title II enforcement, and EU AI Act high-risk obligations, evidence is the bar.

Framework coverage

Drata: SOC 2 + ISO 27001 are deep. HIPAA, GDPR, PCI, CCPA are supported with broader nominal breadth than Vanta. Strength: more framework names on the box than Vanta. Limitation: same documentation-vs-evidence architectural ceiling regardless of framework count. Adding more frameworks doesn't change what kind of evidence the platform produces.

Acipta: 7 GA suites · 117 agents at Full GA, with more on the post-GA roadmap. Each suite is purpose-built with agents specific to the framework's controls (HIPAA Privacy Rule, GDPR Articles, ADA Title II + WCAG 2.1 AA, EU AI Act high-risk + GPAI). Coverage isn't a checkbox; it's per-control agent depth. Strength: when the platform claims HIPAA support, the agents enforce HIPAA-specific controls and emit HIPAA-specific evidence. Limitation: customer-validated depth-vs-breadth comparison waits until Full GA + 90 days.

Pricing

Drata pricing is sketched from publicly available case studies and G2 reviews — verify directly.

Implementation + support

Drata: standard SaaS implementation. Strong customer-success motion at mid-market+. Continuous-monitoring UX means less reconfiguration as your environment changes. G2 reviews consistently highlight implementation and support quality.

Acipta: design partner program through Full GA. Post-Full GA, Business+ tier includes dedicated CSM and white-glove migration from Drata, Vanta, OneTrust, or Siteimprove. Implementation is policy-import + agent-instantiation rather than connector-config.

Who should choose Drata

You're a mid-market SaaS company. SOC 2 + ISO 27001 are your compliance scope for the next 24 months. You value continuous-monitoring UX. You've evaluated Vanta and prefer Drata's interface. You have a CISO leading the program with light CPO involvement.

Drata is the right call. The monitoring posture is sharper than Vanta's at this profile.

Ideal Drata customer: 100-500 person mid-market SaaS, SOC 2 Type 2 + ISO 27001 + possibly HIPAA, CISO-led, established compliance program with continuous-monitoring requirements.

Who should choose Acipta

You're a Chief Compliance Officer serving multiple frameworks and multiple stakeholders. Your worst-case audit isn't "show us your documentation" — it's "prove this was in place on this date in this state of the system." You expect the framework portfolio to grow over the next 24 months. You want one evidence chain across security, privacy, accessibility, and the next thing.

Ideal Acipta customer: Series B-D SaaS in regulated verticals (healthcare, financial services, gov / higher ed, AI/ML companies subject to EU AI Act). CCO-owned compliance with CISO + CPO partnership.

Running Acipta alongside Drata — the third option

Choosing one isn't the only outcome, and for some programs it isn't the right one. Drata runs the operational core of a compliance program: automated control monitoring, policy management, access reviews, risk registers, and — through its trust center — customer-facing security reviews and questionnaire automation. Acipta doesn't replace that operational layer and doesn't try to. Acipta answers a different question: when an auditor, regulator, or enterprise customer challenges your evidence, can you prove it — reproducibly, years later?

To scope the split cleanly, here is what Acipta deliberately does not do: policy template libraries, security awareness training, device management, questionnaire automation at Drata's maturity, or Drata's breadth of SaaS configuration integrations. Those stay in Drata. And here is what Drata's monitoring-based evidence model doesn't do: evidence signed at write time, tamper-evident, deterministically replayable, retained for five years on every tier — with one evidence artifact projecting to multiple frameworks instead of being re-collected per framework.

Teams run both when:

• Drata is embedded for SOC 2 / ISO 27001 operations, but a regulated product line — healthcare data, EU AI Act exposure, accessibility obligations — needs evidence built to survive adversarial review, not just pass a friendly audit.
• An auditor or a major customer has started asking "how do you know this evidence hasn't changed since it was collected?" — a question monitoring snapshots can't answer.
• The framework portfolio is expanding and the team is re-collecting the same evidence for each new framework.

In that setup, Drata stays the system of record for how your program runs; Acipta is the layer of review that makes what your program produces defensible. The two don't compete for the same job — they compete for the same budget line, which is a conversation about risk, not features.

Switching from Drata

(Migration tooling lands in real form post-GA. Provisional notes below.)

What transfers cleanly:

• Controls catalog (mapped to Acipta's Control Mapping Catalog)
• Framework checklists (re-mapped automatically)
• Integration credentials (where Acipta supports the same connector)
• Policies (imported and version-pinned)

What needs reconfiguration:

• Drata's monitoring rules don't map one-to-one to Acipta's agent definitions. Migration is policy-import + agent-instantiation, not rule-conversion. We provide a per-customer migration map.
• Evidence chain restarts at Acipta. Drata-stored evidence remains in Drata and is exportable; new evidence emits from Acipta with the cryptographic chain forward.

Migration support: design partners get white-glove migration. Post-Full GA, included in Business+ and Enterprise. Typical timeline: 2-4 weeks for mid-market SaaS.

FAQ

Q: Drata's continuous monitoring catches drift fast. How does Acipta compare? A: Acipta's agents run on configurable cadences down to 5-minute intervals for high-stakes controls. The architectural difference isn't speed of detection; it's what the detection produces. Drata produces an alert + a queue entry. Acipta produces a signed verdict that joins the evidence chain whether the finding is PASS or FAIL. The verdict is what survives to the audit five years later.

Q: Drata is cheaper at scale than Acipta's Business+ tier. Is Acipta priced correctly? A: Drata's mid-market quotes typically land at $15K-$35K/year. Acipta Business+ at $999/month is $11,988/year. The pricing structure is different because the value structure is different — Acipta consolidates a multi-framework stack rather than excelling at a single framework. For SOC 2-only at scale, Drata is cheaper. For SOC 2 + HIPAA + GDPR + WCAG, Acipta's consolidated price beats the multi-tool stack materially.

Q: Is Drata's continuous monitoring already enough for HIPAA? A: For self-attestation, often yes. For an actual HIPAA audit by a covered entity's auditor, HHS OCR inquiry, or a Joint Commission survey, documentation-grade evidence with monitoring snapshots is increasingly questioned. The bar is "prove this technical safeguard was in place on this date" — cryptographic evidence answers that question directly; monitoring data requires interpretation.

Q: Can Acipta replicate Drata's continuous-monitoring UX? A: The dashboard surface is comparable — both platforms show real-time compliance posture with drift alerts. The architectural difference is what the dashboard is rendering. Drata's dashboard reflects monitoring data; Acipta's dashboard reflects the latest verdict in the evidence chain. Functionally similar at the UI; materially different at the data layer.

Q: Is Acipta SOC 2 Type 2 yet? A: Compliance program in flight. All 7 suites are generally available at Full GA on August 23, 2026; the SOC 2 Type 2 and HIPAA certifications are targeted for August 30, 2026.

Q: We already run Drata and don't want to rip it out. Does Acipta still make sense? A: Yes — keep it. Drata stays your system of record for program operations (monitoring, policies, access reviews, questionnaires); Acipta adds the defensible-evidence layer for the parts of your business where evidence gets challenged, not just checked. See "Running Acipta alongside Drata" above for when the two-tool setup earns its cost.

Bottom line

Drata built a sharper continuous-monitoring UX than Vanta for similar framework coverage. We respect Drata's engineering and we recommend Drata to single-framework or 2-framework programs where SOC 2 + ISO 27001 is the scope and continuous monitoring is the priority.

Acipta is built for the buyer Drata wasn't built for: the Chief Compliance Officer whose audit defensibility depends on cryptographic evidence chains and whose program crosses security, privacy, accessibility, and AI governance.

The right question isn't Drata vs Acipta on a feature checklist. It's: in 24 months, will your compliance program look more like SOC 2 + ISO 27001 (Drata's bet) or more like SOC 2 + HIPAA + GDPR + ADA + EU AI Act (Acipta's bet)? Buy for that future.

Related comparisons + internal links

Hub · shortlisting multiple platforms? Acipta vs Vanta vs Drata vs OneTrust vs Siteimprove — Which Compliance Platform Is Right for You?

Other one-on-one comparisons:

• Acipta vs Vanta — SOC 2 specialist vs multi-framework platform
• Acipta vs OneTrust — privacy-only F1000 vs multi-framework consolidation
• Acipta vs Siteimprove — marketing-owned accessibility vs CCO-owned compliance

Acipta overview:

• Platform overview — 117 agents · 7 GA suites · cryptographic evidence chain
• Pricing — $99 Starter / $199 Team / $499 Pro / $999 Business+ / Custom Enterprise
• full suite catalog — ADA / WCAG · HIPAA · GDPR · CCPA · Privacy · EU AI Act + ISO 42001 · Security-GRC / SOC 2 (with more on the post-GA roadmap)
• Early access — ADA + Early Access · July 12, 2026 · design partner program through Full GA (2026-08-23)

Agent-based defensibility platform — workflow-grounded.